The Oncology Care Model-Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment.

This Viewpoint argues that changing the Oncology Care Model to hold clinicians accountable for inappropriate drug utilization, not drug costs, could improve the model while preventing unintended disincentives to clinicians for using effective treatments.